Abstract
Hepatocellular carcinoma has a poor prognosis and is poorly responsive to systemic chemotherapy. Here we describe a case with unresectable hepatocellular carcinoma who achieved a complete response and has survived for more than 2 years, following treatment with a combination of adriamycin and etoposide (VP 16-213).
MeSH terms
-
Antineoplastic Combined Chemotherapy Protocols / therapeutic use*
-
Carcinoma, Hepatocellular / drug therapy*
-
Carcinoma, Hepatocellular / mortality
-
Doxorubicin / administration & dosage
-
Etoposide / administration & dosage
-
Female
-
Humans
-
Liver Neoplasms / drug therapy*
-
Liver Neoplasms / mortality
-
Middle Aged